Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Alaunos Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- 0 vs. Q3 2022
- Shares held
- 77.9M
- +3.22M (+4.3%) vs. Q3 2022
- Total value
- $50.5M
- −$78.0M (−60.7%) vs. Q3 2022
- New holders
- 25
- 22 more added
- Sold out
- 25
- 32 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $204.4K |
| Q1 2026 | 29 | $360.5K |
| Q4 2025 | 27 | $349.9K |
| Q3 2025 | 26 | $158.3K |
| Q2 2025 | 28 | $344.6K |
| Q1 2025 | 29 | $103.4K |
| Q4 2024 | 30 | $137.0K |
| Q3 2024 | 29 | $622.8K |
| Q2 2024 | 50 | $1.69M |
| Q1 2024 | 46 | $4.23M |
| Q4 2023 | 86 | $2.96M |
| Q3 2023 | 92 | $7.36M |
| Q2 2023 | 102 | $34.2M |
| Q1 2023 | 110 | $44.7M |
| Q4 2022 | 124 | $50.5M |
| Q3 2022 | 125 | $128.6M |
| Q2 2022 | 125 | $90.7M |
| Q1 2022 | 149 | $65.8M |
| Q4 2021 | 167 | $155.9M |
| Q3 2021 | 163 | $194.1M |
| Q2 2021 | 156 | $297.6M |
| Q1 2021 | 153 | $422.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Alaunos Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 425,525 | $276.2K | 0.00% | −1,067−0.3% | Reduced |
| Marshall Wace, LLP | 451,698 | $293.6K | 0.00% | −1,509,429−77.0% | Reduced |
| Commerce Bank | 459,000 | $297.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 488,097 | $316.8K | 0.00% | −791,945−61.9% | Reduced |
| Alyeska Investment Group, L.P. | 500,000 | $324.6K | 0.00% | +500,000 | New |
| Advisor Group Holdings, Inc. | 552,229 | $358.4K | 0.00% | −30,511−5.2% | Reduced |
| Citadel Advisors LLC | 753,629 | $489.2K | 0.00% | +682,666+962.0% | Added |
| State Street Corp | 782,025 | $507.6K | 0.00% | −2,396,398−75.4% | Reduced |
| Gsa Capital Partners LLP | 957,348 | $621.0K | 0.08% | +349,311+57.4% | Added |
| Morgan Stanley | 1,419,833 | $921.6K | 0.00% | +673,822+90.3% | Added |
| Boxer Capital, LLC | 1,500,000 | $973.6K | 0.05% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,578,700 | $1.02M | 0.00% | +1,578,700 | New |
| Two Sigma Investments, LP | 1,636,823 | $1.06M | 0.00% | +1,209,914+283.4% | Added |
| Two Sigma Advisers, LP | 1,937,792 | $1.26M | 0.00% | +628,300+48.0% | Added |
| Geode Capital Management, LLC | 2,094,338 | $1.36M | 0.00% | +17,840+0.9% | Added |
| JPMorgan Chase & Co | 2,516,585 | $1.63M | 0.00% | −8,658−0.3% | Reduced |
| Green Square Capital Advisors LLC | 2,730,000 | $1.77M | 0.25% | +1,650,000+152.8% | Added |
| BlackRock Inc. | 5,433,334 | $3.53M | 0.00% | +243,292+4.7% | Added |
| Laurion Capital Management LP | 5,720,500 | $3.71M | 0.10% | +1,500,000+35.5% | Added |
| Vanguard Group Inc | 9,147,741 | $5.94M | 0.00% | −14,782−0.2% | Reduced |
| MSD Partners, L.P. | 15,151,516 | $9.83M | 1.14% | 00.0% | Unchanged |
| Discovery Capital Management, LLC | 16,185,998 | $10.5M | 1.56% | +1,543,039+10.5% | Added |
| IFP Advisors, Inc | 17,258 | – | – | +3,469+25.2% | Added |
| Addison Capital Co | 15,870 | – | – | +15,870 | New |
| EAM Investors, LLC | 0 | $0 | 0.00% | −454,625−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −349,867−100.0% | Sold out |
| Kettle Hill Capital Management, LLC | 0 | $0 | 0.00% | −323,940−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −235,600−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −220,543−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −136,136−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −99,692−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −74,592−100.0% | Sold out |
| Silverlake Wealth Management LLC | 0 | $0 | 0.00% | −56,993−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −52,635−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −51,345−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −44,550−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −42,441−100.0% | Sold out |
| Act Wealth Management, LLC | 0 | $0 | 0.00% | −38,476−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −36,500−100.0% | Sold out |
| Concorde Asset Management, LLC | 0 | $0 | 0.00% | −35,500−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −33,327−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −24,295−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −23,724−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −15,167−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −13,600−100.0% | Sold out |
| SPC Financial, Inc. | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −12,843−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −4,097−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −1,975−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |